Invesco
TEVA icon

Invesco’s Teva Pharmaceuticals TEVA Stock Holding History

Invesco’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98M Buy
3,253,233
+543,128
+20% +$17.5M 0.01% 849
2025
Q4 		$84.6M Buy
2,710,105
+124,304
+5% +$3.06M 0.01% 893
2025
Q3 		$52.2M Sell
2,585,801
-1,014,243
-28% -$17.8M 0.01% 1075
2025
Q2 		$60.3M Sell
3,600,044
-1,087,208
-23% -$17.5M 0.01% 987
2025
Q1 		$72M Sell
4,687,252
-1,377,277
-23% -$24.6M 0.01% 900
2024
Q4 		$134M Buy
6,064,529
+355,581
+6% +$6.47M 0.02% 724
2024
Q3 		$103M Buy
5,708,948
+959,358
+20% +$16.8M 0.02% 789
2024
Q2 		$77.2M Buy
4,749,590
+4,540,171
+2,168% +$69.9M 0.02% 854
2024
Q1 		$2.95M Sell
209,419
-705
-0.3% -$8.89K ﹤0.01% 2498
2023
Q4 		$2.19M Sell
210,124
-8,775
-4% -$81.9K ﹤0.01% 2579
2023
Q3 		$2.23M Buy
218,899
+2,557
+1% +$23.8K ﹤0.01% 2559
2023
Q2 		$1.63M Sell
216,342
-50,350
-19% -$408K ﹤0.01% 2701
2023
Q1 		$2.36M Sell
266,692
-114,093
-30% -$1.13M ﹤0.01% 2573
2022
Q4 		$3.47M Buy
380,785
+2,643
+0.7% +$23.1K ﹤0.01% 2418
2022
Q3 		$3.05M Buy
378,142
+14,231
+4% +$126K ﹤0.01% 2459
2022
Q2 		$2.74M Buy
363,911
+15,116
+4% +$132K ﹤0.01% 2574
2022
Q1 		$3.27M Buy
348,795
+4,097
+1% +$34.2K ﹤0.01% 2581
2021
Q4 		$2.76M Sell
344,698
-385,785
-53% -$3.48M ﹤0.01% 2671
2021
Q3 		$7.12M Sell
730,483
-235,841
-24% -$2.21M ﹤0.01% 2201
2021
Q2 		$9.57M Buy
966,324
+98,831
+11% +$1.05M ﹤0.01% 2081
2021
Q1 		$10M Sell
867,493
-676,632
-44% -$7.76M ﹤0.01% 1949
2020
Q4 		$14.9M Buy
1,544,125
+202,388
+15% +$1.94M ﹤0.01% 1590
2020
Q3 		$12.1M Sell
1,341,737
-482,973
-26% -$5.11M ﹤0.01% 1560
2020
Q2 		$22.5M Sell
1,824,710
-210,206
-10% -$2.38M 0.01% 1234
2020
Q1 		$18.3M Buy
2,034,916
+1,594,441
+362% +$16.3M 0.01% 1240
2019
Q4 		$4.32M Buy
440,475
+271,981
+161% +$2.43M ﹤0.01% 2246
2019
Q3 		$1.16M Buy
168,494
+49,918
+42% +$382K ﹤0.01% 2915
2019
Q2 		$1.09M Buy
118,576
+63,585
+116% +$767K ﹤0.01% 3022
2019
Q1 		$862K Buy
54,991
+14,730
+37% +$260K ﹤0.01% 3093
2018
Q4 		$621K Sell
40,261
-7,297
-15% -$150K ﹤0.01% 3189
2018
Q3 		$1.02M Sell
47,558
-32,459
-41% -$754K ﹤0.01% 3133
2018
Q2 		$1.95M Sell
80,017
-39,790
-33% -$811K ﹤0.01% 2778
2018
Q1 		$2.05M Sell
119,807
-2,154,622
-95% -$42.1M ﹤0.01% 2572
2017
Q4 		$43.1M Sell
2,274,429
-9,942,473
-81% -$150M 0.02% 839
2017
Q3 		$215M Sell
12,216,902
-2,517,972
-17% -$56.7M 0.08% 283
2017
Q2 		$489M Sell
14,734,874
-66,245
-0.4% -$2.05M 0.15% 148
2017
Q1 		$475M Sell
14,801,119
-65,084
-0.4% -$2.22M 0.16% 143
2016
Q4 		$539M Buy
14,866,203
+557,681
+4% +$22.3M 0.18% 118
2016
Q3 		$658M Sell
14,308,522
-520,153
-4% -$27.1M 0.23% 88
2016
Q2 		$745M Sell
14,828,675
-4,077,251
-22% -$217M 0.27% 73
2016
Q1 		$1.01B Sell
18,905,926
-439,575
-2% -$25.8M 0.41% 36
2015
Q4 		$1.27B Buy
19,345,501
+45,177
+0.2% +$2.79M 0.51% 25
2015
Q3 		$1.09B Sell
19,300,324
-1,770,625
-8% -$115M 0.46% 30
2015
Q2 		$1.25B Sell
21,070,949
-1,045,741
-5% -$64.5M 0.49% 27
2015
Q1 		$1.38B Buy
22,116,690
+1,691,669
+8% +$98.4M 0.53% 24
2014
Q4 		$1.17B Buy
20,425,021
+494,959
+2% +$27.6M 0.45% 30
2014
Q3 		$1.07B Buy
19,930,062
+303,293
+2% +$16.1M 0.43% 30
2014
Q2 		$1.03B Buy
19,626,769
+5,004,774
+34% +$256M 0.4% 34
2014
Q1 		$773M Buy
14,621,995
+4,378,244
+43% +$202M 0.31% 53
2013
Q4 		$411M Sell
10,243,751
-4,147,704
-29% -$163M 0.16% 128
2013
Q3 		$544M Buy
14,391,455
+2,237,612
+18% +$87.3M 0.24% 83
2013
Q2 		$476M Buy
+12,153,843
New +$473M 0.22% 94

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco's TEVA Position: Q1 2026 in Review

Invesco increased its Teva Pharmaceuticals (TEVA) stake by 20% in Q1 2026, buying an estimated $17.5M and bringing the position to 3,253,233 shares worth $98M. The position accounts for 0.01% of the portfolio, ranked #849.

Invesco first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.38B in Q1 2015. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Invesco held 3,253,233 shares of Teva Pharmaceuticals worth $98M as of Q1 2026.
  • Invesco bought 543,128 Teva Pharmaceuticals shares in Q1 2026, an estimated $17.5M.
  • Teva Pharmaceuticals made up 0.01% of Invesco's portfolio in Q1 2026, its #849 holding.
  • Invesco first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Invesco's Teva Pharmaceuticals position peaked at $1.38B in Q1 2015.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.